Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| I think things have continued on -- certainly on a year-over-year basis, still very strong, coming off of what was a strong business environment in Q3, I think it's kind of continued to be a reasonably strong business environment in Q4 |
| The lab is growing nicely along with the business |
| I do think the first quarter, from a margin perspective, it's likely to be better than the balance of the year, similar to what we saw this year just because some of the wage inflation pressures will pick up again and the end of the first quarter, beginning of the second quarter this year |
| And this may be a low year of 15% but long term, we've grown well above the industry |
| At the same time, 15% revenue guidance, consistent, very good, excellent compared to the peer group |
| So I just -- we're clearly doing a good job in terms of taking share |
| I said, kind of initial awards were kind of record and our fees were very strong, et cetera |
| And if anything, we see an improvement in the business environment, which would imply greater growth in the Q4 next year kind of time frame |
| They were very strong last quarter |
| Like I said, I think we see a clear direction in the last three, four months in terms of projects starting to install, and that makes us very optimistic |
| So that looks good |
| And the things we've invested in recently and things we've added have been off to a good start |
| I think things are improving from a funding standpoint |
| Full year EBITDA was $362.5 million and increased 17.7% from the comparable prior year period |
| So I think we're -- it's still a post-volatile period, and there may be more volatility but I think we're more and more seeing a trend towards improvement on the funding side and project progression side |
| So I think our -- we got a bit ahead when we're growing very fast |
| This represented a year-over-year increase of 26.5% on a reported basis and 26% on a constant currency basis |
| These things do take quite a bit of time but things are looking very good for that |
| For the full year 2023, net new business awards were $2.36 billion, an increase of 28.8% and ending backlog as of December 31, 2023, was approximately $2.8 billion, an increase of 20.2% from the prior year |
| Full year 2023 revenue was $1.89 billion and increased 29.2% on a reported basis and 28.9% on a constant currency basis from 2022 |
| Full year 2023 revenue was $1.89 billion, a 29.2% increase from 2022 |
| Jack Wallace Excellent |
| So I think the big driver is that productivity increase |
| Net new business awards entering backlog in the fourth quarter increased 26.7% from the prior year to $614.7 million, resulting in a 1.23 net book-to-bill |
| But I did notice that your customers out of your top 10 look like they were down sequentially in the quarter in terms of revenue, and I wasn't sure if that comp was any more at that cohort or if there's anything else to call out with that revenue trend because it does sound like everything you're saying is that things are going well and continue to get better and expected to get even better than that |
| Our revenue for the fourth quarter of 2023 was $498.4 million, which represents a year-over-year increase of 26.5% |
| But yes, just to give you an idea, they remain strong |
| Net income growth lagging EBITDA growth was primarily driven by a higher effective tax rate of 15.8% compared to 13.3% in the prior year period |
| In the fourth quarter of 2023, net income of $78.3 million increased 14% compared to net income of $68.7 million in the prior year period |
| Eric Coldwell That's actually somewhat reassuring and good, I think |
| Statement |
|---|
| So on one hand, really tough comps going into '24 |
| What we've heard from some peers is some slowing of activity in the second half of '23, particularly maybe the last couple of months of '23 in the biotech space |
| And of course, we're not giving guidance on '24 but things look good in terms -- we had a very choppy period and quite a bit of cancellations and funding difficulties |
| Lot of difficulty and a lot of a very strong business environment |
| I don't know if that's driving any particular -- we had a spike in 2022 but things came down after -- maybe after first quarter to a reasonable rate in the Q2 through Q4 |
| Of course, if you -- if the smaller clients are starting to unfreeze, eventually that leads to proportional reduction in top 10 revenue because you get other newer clients coming in |
| If I look at what has for you guys been a pretty consistent burn rate, you're entering '24 at a 20% backlog growth, that revenue growth rate is that you're projecting is a little lower than that |
| But I think things have shown a correction |
| I think there was a very volatile time there in Q3, certainly and extending into Q4 |
| Now when or if we'll see a retraction back to more normal levels, it remains to be seen but we do expect it to remain elevated here through 2024 |
| I think that we were thinking that turnover might still be high so we have to continue to hire at a fast rate |
| But then you also were a little lighter than you have been on hiring in the fourth quarter |
| We weren't quite sure why |
| In the fourth quarter, we generated $156.4 million in cash flow from operating activities, and our net days sales outstanding was negative 48.3 days |
| I don't -- these things do bounce around though |
| And so there's nothing that I would call out necessarily specifically in terms of do we see an acceleration in Q1 and a drop-off? Or do we kind of see steady state throughout the quarter and you see sequential growth throughout the quarters? I guess I don't know the answer to that, as August had mentioned, if things do pick up, there's a possibility that you start to see some acceleration in the fourth quarter and into 2025 |
| Turnover has really come down to a very, very tight level |
| But it does bounce around a little bit |
| Yeah, Dave, I think our burn rate -- our conversion rate does bounce around a bit |
| EBITDA margin compared to the prior year was impacted by higher reimbursable costs, personnel costs and the foreign exchange benefit in 2022 behind the strong US dollar |
Please consider a small donation if you think this website provides you with relevant information